Covid19 Archives - Page 2 Of 3

EXPLAINER: How Does COVID-19 Affect the Heart? | Health News

The proof is distinct: COVID-19 an infection is risky for the coronary heart.

Approximately a few yrs into the pandemic, research right after study has proven that while COVID-19 at first sparked problems about the lungs, consideration is overdue for the heart.

“I feel we have to have to start conceptualizing and wondering of COVID as a possibility component for coronary heart disorder,” says Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis.

It’s an crucial trend to fully grasp as extra than 100 million Us citizens have experienced COVID-19 – a variety that carries on to increase every single day with no signs of ceasing.

A modern investigation from the American Heart Affiliation located that deaths connected to coronary heart illness rose appreciably in the course of 2020, the initially yr of the pandemic. The number of People who died from cardiovascular illness jumped from 874,613 fatalities in 2019 to 928,741 in 2020 – topping the past significant of 910,000 recorded in 2003.

Probably additional notable was that the age-altered mortality price, which accounts for adjustments in the variety of more mature adults in the inhabitants from yr to calendar year, increased in 2020 for the initial time in a ten years.

“COVID-19 has each immediate and oblique impacts on cardiovascular health and fitness,” Michelle Albert, the American Coronary heart Association’s volunteer president, claimed in a statement. “As we uncovered, the virus is associated with new clotting and irritation. We also know that several persons who had new or present coronary heart illness and stroke signs and symptoms were hesitant to look for medical treatment, specially in the early days of the pandemic.”

The 7 days in Cartoons July 18-22

EXPLAINER: How Does COVID-19 Affect the Heart? | Health News

The sample has been documented by other teams as well. The Smidt Coronary heart Institute at Cedars-Sinai discovered in an evaluation that fatalities from heart assaults rose drastically all through COVID-19 surges. The pattern was outstanding throughout all age groups but most significant between people ages 25-44, which is an age team that is not usually considered at superior chance for a coronary heart assault.

“There is something quite different about how this virus influences the cardiac threats,” Susan Cheng of the Smidt Heart Institute stated in a statement about the research. “The change is most likely owing to a blend of pressure and swelling, arising from predisposing elements and the way this virus biologically interacts with the cardiovascular program.”

Yet another latest examine out of the United Kingdom located that individuals infected with COVID-19 had a larger likelihood of quite a few cardiovascular disorders as opposed with uninfected participants in equally the short expression and long expression, like myocardial infarction, coronary coronary heart sickness, coronary heart failure and deep vein thrombosis. The authors recommended that the results indicate that COVID-19 people really should be monitored for at minimum a 12 months after recovery from an infection to diagnose cardiovascular complications.

COVID-19 can have an affect on the coronary heart even if a person’s coronavirus an infection is delicate. Analysis from Al-Aly that was published past calendar year found that individuals who were reinfected had been 2 times as very likely to die and 3 moments more most likely to be hospitalized than those who had been infected at the time. They had been also a few situations a lot more likely to put up with from heart difficulties.

“However we sliced it with weighted analyses by age and race and sexual intercourse and prior professional medical situations, the chance was in all places, which means it truly almost did not spare anybody,” Al-Aly suggests.

Authorities estimates demonstrate that the majority of the U.S. has been infected with the coronavirus. It is drastically bigger than the official range offered that infections can be asymptomatic and the outcomes from at-property exams are not automatically documented. The large range signifies much more focus requirements to change to all those who are getting infected a second, 3rd or fourth time as many specialists imagine COVID-19 will proceed circulating for a long time to occur.

“Reinfection is extra and extra turning out to be the norm mainly because most of the folks in the U.S. have had it at minimum once,” Al-Aly suggests.

Which is why he options to carry on the review to glance beyond the a person-year mark. He hypothesizes that at some level – he indicates possibly the fifth, sixth or seventh COVID-19 infection – any infection after that level will maybe be just like a cold.

“We assume that eventually, the threat perhaps will flatten with time,” Al-Aly suggests.

Investigate on COVID-19’s effect on the coronary heart is increasing, but researchers agree that extra notice is needed. A preprint research posted on medRxiv past month executed a systematic evaluation of far more than 100 scientific tests examining COVID-19 and prolonged-phrase cardiac signs or symptoms. The substantial-high quality experiments that they determined believed 4{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of COVID-19 survivors described upper body soreness and just about 3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} reported heart arrhythmia. The authors emphasised that although these percentages appear little, they equate to a lot of individuals.

“Accumulating proof shows that long-time period cardiac signs of COVID-19 are widespread and can very last for months and even beyond one particular calendar year,” authors wrote in the review.

It is rare for COVID-19 to directly infect the coronary heart muscle mass. The virus normally will cause issues in other parts of the body that can bring about coronary heart destruction.

“Even if the virus is not exclusively impacting your coronary heart, it could be impacting your lungs or an additional organ that’s demanding the coronary heart now to do the job tougher to compensate for that,” claims Jayne Morgan, a cardiologist and the government director of well being and local community schooling at Piedmont Healthcare in Atlanta.

A lot awareness has especially been paid to myocarditis – a issue in which the heart gets infected that is ordinarily a reaction to a viral an infection. Irritation of the heart can cut down its potential to pump blood to the relaxation of the human body. Most situations are self-resolving and go absent in two months. But the scarce instances that last for a longer period than two months are regarded persistent and can substantially weaken the heart, top to coronary heart failure and loss of life.

“When we speak about myocarditis, it can be extremely, extremely severe or it can be self limiting,” Morgan claims. “So it truly is nearly the very same game of Russian roulette that you happen to be enjoying with having COVID. You can get a incredibly moderate sort or you can die from it. You just just take the risk, so having multiple infections and finding reinfected and reinfected only boosts your threat of last but not least obtaining the bullet in the chamber.”

Myocarditis has also been a recurrent matter between COVID-19 vaccine skeptics, who have seized on a connection in between the mRNA shots from Pfizer and Moderna and myocarditis. Just lately, skeptics were brief to improperly blame the collapse of Buffalo Costs basic safety Damar Hamlin on the vaccine as he suffered cardiac arrest through a match in January.

And in Florida, the surgeon standard last 12 months encouraged in opposition to the use of mRNA COVID-19 vaccines in adult males ages 18-39, indicating that the “benefit of vaccination is likely outweighed by this abnormally higher hazard of cardiac-relevant dying among the males in this age team.” The selection was slammed by many health and fitness officials.

A analyze out of England past 12 months found that people today infected with COVID-19 in advance of receiving a vaccine have been 11 times extra at threat for establishing myocarditis inside of 28 times of tests favourable for the virus. This threat was slice in half for folks who had obtained at least just one dose of vaccine.

“Myocarditis is an uncommon issue,” the authors wrote in the analyze. “The hazard of vaccine-related myocarditis is small, with up to an additional 2 situations for each million persons in the 28-day time period right after exposure to all vaccine doses other than mRNA-1273. This is significantly lessen than the 35 more myocarditis functions observed with SARS-CoV-2 an infection prior to vaccination.”

Al-Aly suggests it is nevertheless important to accept that vaccine personal injury is true.

“They absolutely direct in rare scenarios to coronary heart complications together with, most notoriously, myocarditis,” he says. “But the rates are logs of magnitude decrease than the premiums of myocarditis, for illustration, or other heart challenges with COVID.”

China’s COVID-19 Surge Raises Odds of New Coronavirus Mutant

Could the COVID-19 surge in China unleash a new coronavirus mutant on the world?

Scientists do not know but get worried that could occur. It could be related to omicron variants circulating there now. It could be a combination of strains. Or something entirely unique, they say.

“China has a populace that is incredibly big and there’s confined immunity. And that seems to be the location in which we may possibly see an explosion of a new variant,” said Dr. Stuart Campbell Ray, an infectious sickness expert at Johns Hopkins University.

Each individual new infection delivers a chance for the coronavirus to mutate, and the virus is spreading quickly in China. The place of 1.4 billion has mainly abandoned its “zero COVID” policy. Though total noted vaccination charges are significant, booster degrees are decreased, especially amongst more mature people today. Domestic vaccines have verified a lot less effective against really serious infection than Western-designed messenger RNA variations. Numerous were specified more than a yr ago, which means immunity has waned.

The final result? Fertile ground for the virus to modify.

Political Cartoons on Environment Leaders

China’s COVID-19 Surge Raises Odds of New Coronavirus Mutant

Political Cartoons

“When we have seen huge waves of an infection, it’s normally adopted by new variants being generated,” Ray explained.

About a few yrs in the past, the unique version of the coronavirus distribute from China to the relaxation of the globe and was finally replaced by the delta variant, then omicron and its descendants, which keep on plaguing the globe now.

Dr. Shan-Lu Liu, who research viruses at Ohio State College, said a lot of existing omicron variants have been detected in China, which include BF.7, which is incredibly adept at evading immunity and is believed to be driving the present-day surge.

Professionals reported a partially immune inhabitants like China’s places unique stress on the virus to modify. Ray when compared the virus to a boxer that “learns to evade the abilities that you have and adapt to get around these.”

Just one huge unknown is no matter whether a new variant will cause extra significant disorder. Authorities say there is no inherent biological reason the virus has to come to be milder above time.

“Much of the mildness we have knowledgeable about the earlier six to 12 months in numerous elements of the globe has been owing to gathered immunity possibly as a result of vaccination or infection, not since the virus has adjusted” in severity, Ray claimed.

In China, most people have never ever been exposed to the coronavirus. China’s vaccines depend on an more mature engineering generating fewer antibodies than messenger RNA vaccines.

Specified those people realities, Dr. Gagandeep Kang, who scientific studies viruses at the Christian Health care Faculty in Vellore, India, said it stays to be noticed if the virus will abide by the identical pattern of evolution in China as it has in the relaxation of the environment immediately after vaccines came out. “Or,” she asked, “will the sample of evolution be completely distinctive?”

Just lately, the Entire world Health Business expressed worry about reports of severe sickness in China. Close to the metropolitan areas of Baoding and Langfang outdoors Beijing, hospitals have operate out of intensive treatment beds and staff members as severe instances surge.

China’s system to observe the virus centers about three town hospitals in each individual province, the place samples will be gathered from wander-in patients who are extremely unwell and all individuals who die each and every 7 days, Xu Wenbo of the Chinese Middle for Condition Command and Prevention stated at a briefing Tuesday.

He reported 50 of the 130 omicron variations detected in China had resulted in outbreaks. The region is developing a national genetic databases “to observe in genuine time” how unique strains ended up evolving and the likely implications for public well being, he mentioned.

At this level, having said that, there’s limited info about genetic viral sequencing coming out of China, stated Jeremy Luban, a virologist at the University of Massachusetts Health care School.

“We don’t know all of what’s likely on,” Luban explained. But evidently, “the pandemic is not above.”

AP video clip producer Olivia Zhang and reporter Dake Kang in Beijing contributed to this report.

The Related Push Well being and Science Division gets assistance from the Howard Hughes Healthcare Institute’s Science and Academic Media Team. The AP is exclusively accountable for all articles.

Large-scale review of COVID-19 clinical trials highlights multiple disparities

Women were underrepresented in COVID-19 treatment clinical trials, and some racial and ethnic groups were underrepresented in COVID-19 prevention trials, according to a new meta-analysis conducted by Fred Hutchinson Cancer Center in collaboration with researchers from Beijing and London.

The study, published Dec. 5 in JAMA Internal Medicine, identified system-wide differences in representation among several key demographic groups in COVID-19 prevention and treatment trials in the U.S.

“To our knowledge, this is the first study to comprehensively examine demographic representation across the landscape of both COVID-19 prevention and treatment trials over the first two years of this pandemic,” said Hong Xiao, Ph.D., researcher in the Public Health Sciences Division at Fred Hutch and the lead author for the study.

By the numbers

Overall, the meta-analysis examined 122 U.S.-based clinical trials for COVID-19 vaccines or treatments, involving more than 175,000 participants. The selected trials were those registered on ClinicalTrials.gov or published in PubMed from October 2019 to February 2022.

Only studies that provided data about enrolled participants by sex, race or ethnicity were analyzed in this study. Representation rates from trials were compared to expected rates in the U.S. COVID-19 population.

Takeaways

Key findings from their review included:

Sex, race, and ethnicity were reported in 89.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, 77.9{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, and 71.3{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of U.S.-based COVID-19 clinical trials, respectively, suggesting there was a meaningful gap for many studies in this important aspect of trial reporting.
Female participants were underrepresented in treatment trials (85{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of expected participants) but were well represented in COVID-19 prevention trials.
Black and Asian individuals were underrepresented in COVID-19 prevention trials (53.7{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} and 64.4{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of expected participants, respectively), but were well represented in COVID-19 treatment trials.
Hispanic individuals were overrepresented in treatment trials (more than 200{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of expected participants).

Author commentary

The study authors noted that female participants historically have been underrepresented in clinical trials in general for various reasons. Pregnant women have routinely been excluded from clinical trials; as such, women of reproductive age may have had greater concerns about how developmental COVID-19 treatments would affect their health and current or future fertility.

The authors also speculated that Hispanic overrepresentation might have occurred for several reasons, including the fact that one-third of the U.S.-based COVID-19 trial sites were in California, Texas and Florida—areas with large Hispanic populations. Additionally, COVID-19 treatment trials were typically conducted among inpatient populations, which may have disproportionately affected Hispanic populations due to a lack of primary care and increased risk for COVID-associated hospitalizations.

“In many instances, our findings highlight achievements in the successful enrollment of historically underrepresented patients. However, our findings also underscore that despite efforts to eliminate sex, racial and ethnic disparities, gaps in reporting and differences in representation in U.S.-based COVID-19 trials have persisted,” said Joseph M. Unger, Ph.D., MS, Fred Hutch biostatistician and health services researcher and the study’s senior author. “Clearly, more progress needs to occur to fully close these gaps and achieve greater diversity among participants.”

Equitable access

“This vital work by Fred Hutch researchers and their collaborators highlights the ongoing disparities in who accesses and enrolls in clinical research,” added Rachel Bender Ignacio, MD, medical director of the COVID-19 Clinical Research Center at Fred Hutch. “We must remain laser-focused on ensuring that clinical-trial participation is representative of the general population, which both requires trust in and access to research, and also ensures that the products of that research are acceptable to and appropriate for everyone.”

Xiao, Unger and the rest of the study authors concluded that additional strategies are needed to ensure that all trial sponsors, whether federally supported or industry-funded, are held accountable for appropriate representation of females and racial and ethnic groups in clinical trials.

More information:
Hong Xiao et al, JAMA Internal Medicine (2022). DOI: 10.1001/jamainternmed.2022.5600

Provided by
Fred Hutchinson Cancer Center

Citation:
Large-scale review of COVID-19 clinical trials highlights multiple disparities (2022, December 5)
retrieved 5 December 2022
from https://medicalxpress.com/news/2022-12-large-scale-covid-clinical-trials-highlights.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Researchers propose the tools and frameworks of EBM+ to help overcome the COVID-19 pandemic

In a recent article published in BMJ, researchers proposed the tools and frameworks of mechanistic evidence, sometimes known as evidence-based medicine (EBM)+ combined with traditional EBM, might help overcome the highly protracted coronavirus disease 2019 (COVID-19) pandemic.

EBM+ encompasses conceptual tools and quality frameworks from various fields, including complexity science, engineering, and the social sciences, and a more pluralist approach to fetch ‘high-quality’ mechanistic evidence.

Background

Traditional methods, such as randomized controlled trials (RCTs) and meta-analyses, contributed significantly to the science of COVID-19. However, these methods have historically answered simple, focused questions in a stable context, such as those about biomedicine. They have significant limitations when extended to complex situations. In this case, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel pathogen, led to chaos across multiple sectors, medical, social, economic, and political dimensions in a fast-changing global context.

SARS-CoV-2 has proved tenacious and shifting. While RCTs and meta-analyses of RCTs remarkably estimated the efficacy of COVID-19 drugs and vaccines, some scholars argue that tackling some of its aspects critically required mechanistic evidence. COVID-19 led to complex situations where multiple variables interacted dynamically with high uncertainty.

Decisions had to be taken in days (urgently), not years, and the consequences of not acting would have been catastrophic (threatening). In such situations, dismissing mechanistic evidence and overvaluing poorly designed or irrelevant RCT findings cost thousands of lives. Overall, the COVID-19 pandemic presented an epistemic opportunity to understand, debate, and embrace EBM+.

About the study

In the present study, researchers argued that while the hierarchy of evidence that places mechanistic evidence at the bottom and meta-analyses of RCTs at the top is a useful heuristic, but inapplicable to all circumstances. There should be enough guidance to apply hierarchy flexibly depending on the nature of the research question and the extent of complexity involved.

Indeed, RCTs are not a panacea; thus, systemic reviews are crucial to interpret primary evidence along with modifications of the hierarchy of evidence to answer contemporary policy questions pertaining to SARS-CoV-2.

Further, the researchers suggested modifications to the hierarchy of evidence for mechanistic evidence. They emphasized combining evidence of mechanisms with probabilistic evidence from clinical trials and non-randomized studies, both comparative and observational, to make a strong case for causality. It’s because a plausible mechanism confirms or denies the stability of the causal relationship across settings.

This exercise could ensure that public health interventions would work as they involve both the upstream causes and the ’causes’ through which interventions might act. For instance, COVID-19 causes included family structures and their interactions, economic and cultural variations, etc., and attitudes, beliefs, capabilities, and personal resources determined whether public health measures worked. Furthermore, the researchers argued that mechanistic evidence is inherently explanatory.

Early in the pandemic, COVID-19 scientific research was prematurely fixed and constrained to a population-intervention (or exposure)-comparison-outcome (PICO) format that narrowed predefined outcomes and suppressed scientific imagination. Such studies estimated infections in the mask wearer(s) in statistical terms. Still, they failed to account for unique patterns of SARS-CoV-2 spread (e.g., overdispersion, indoor predominance), all of which could have pointed at its predominantly airborne transmission.

An RCT randomized 6,024 people advised wearing masks outside the home. Its results showed infection with SARS-CoV-2 in 42 and 53 people (1.8{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} and 2.1{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}) of the intervention and control arms, respectively, i.e., statistically insignificant. However, EMB supporters argue and evidenced that wearing masks in public does not substantially reduce infection.

The Cochrane Database of Systematic Reviews encouraged policy-makers to adopt the precautionary principle based on the findings of this flawed study because of the urgency of the situation. However, an EBM approach would have accounted for studies elucidating the mechanism(s) by which masking might work. For instance, evidence from:

i) real-world case studies and mathematical modeling studies supporting airborne route of transmission of SARS-CoV-2

ii) Engineering studies showing the filtration properties of different masks

iii) Psychological and socio-cultural evidence of whether people wear masks

Delivering public health interventions and ensuring they are implemented, for instance, face masking, is a complex phenomenon. It has multiple components acting interdependently and individually at multiple levels. Masks could be homemade or produced to formal technical standards. People may mask as socially expected, organisationally required, or legally mandated.

Overall, its adequate implementation is complex in real-world settings for multiple social and behavioral reasons. Thus, complex systems require a new paradigm with designs that could capture dynamic change(s), simultaneously accommodating non-linearity and embracing uncertainty. In support of structural evidence, the researchers discussed how engineering designs account for physical and technical properties and capabilities, social needs, and assessment of impact with the example of personal protective equipment (PPEs).

The use and impact of PPEs are influenced by the quality of indoor air. Yet, an RCT comparing these products with less effective protection to ‘prove’ their value in protecting against chemical contamination in a lead smelter makes no sense. All required is robust certification systems, standards, and workplace usage protocols for PPEs. Currently used PPEs have already proven a boon against occupational hazards for millions of healthcare workers worldwide.

Professor Susan Michie, an adviser to UK’s Scientific Advisory Group on Emergencies, proposed the capability-opportunity-motivation-behavior model. This model helped explain why people prefer or do not prefer wearing a mask. In some cases, they may lack key knowledge (e.g., they may not know whether cloth masks are as effective as surgical masks) or may physically not want to because they are not a good fit. Likewise, they might lack motivation (e.g., conscious beliefs) or opportunity (e.g., employer bans masks). Nevertheless, not exploring these wider influences might produce misleading findings by experimental studies.

Conclusions

In the present study, the authors emphasized more on other sources of evidence, especially mechanistic evidence, to manage the complex and fast-changing COVID-19 pandemic. As the debate regarding EBM+ continues, they hope to contribute further articles on how an EBM+ approach could enhance contribution to pandemic science.

Despite the slowdown in elective medical procedures prompted by the COVID-19 pandemic, 2021 has been a banner year for medical device manufacturers.

ntuitive Surgical opened its Peachtree Corners, Georgia, campus nearly 10 years ago, serving as a primary training facility for surgeons and care teams on the East Coast. For 27 years, the advanced robotic systems company, headquartered in Sunnyvale, California, has changed the landscape of medical practice through minimally invasive robotic-assisted surgery. Dozens of hospitals around Georgia use Intuitive’s systems and technologies, such as the da Vinci, with portions of the da Vinci XI and X systems manufactured in Peachtree Corners, a northeast Atlanta suburb in the metro area’s booming Gwinnett County.

Surgeon operating with da Vinci XI system.

Photo courtesy of Intuitive Surgical.

Intuitive plans to expand its Georgia site to 750,000 sq. ft. with a $500 million investment to include manufacturing and engineering operations, training facilities and administrative offices. Now under construction, the site (about a mile from Site Selection’s headquarters) will be opening in phases until completion, with full operation anticipated by 2024.

“This expansion is part of our broader, multi-year global growth strategy to build and expand global ‘hubs’ where we can best support our customers and all elements of our business,” says Eric Torbenson, senior manager of global public affairs at Intuitive. “Over the next few years, we anticipate adding approximately 1,200 employees in manufacturing, production, distribution, engineering, sales, customer training, customer service and more.”

Torbenson tells Site Selection that access to a strong and diverse talent pool and quality infrastructure were key factors in Intuitive’s decision to expand in Georgia.

Peachtree Corners City Manager Brian Johnson says Intuitive’s investment is the largest economic development project in Gwinnett County’s history. With the creation of 1,200 high-paying jobs, Johnson notes the move is a “game changer” for the community, a win that state and local officials worked hard to score.

The impact on the local economy through increased need for housing, education and retail developments brings challenges that Johnson looks forward to addressing. Investments like Intuitive’s not only bring new talent to the area, but site acquisitions from suppliers as well.

“These are companies that want to be close to the mothership,” Johnson says. “We have definitely had interest and are working with some of those companies now to show why they should move to Peachtree Corners.”

CBRE’s Americas Life Sciences Leader Matthew Gardner says markets like Atlanta are gaining recognition.

“I think that’s a very important signal for the industry to hear they can find a highly educated life sciences workforce in a number of markets around the U.S.”

— Matthew Gardner, Americas Life Sciences Leader, CBRE

“There’s something really interesting as a signal to other multinationals about that decision, which is that a lot of the industry feels like it has matured in Massachusetts and California and has to think about [which] emerging markets should be next,” he says. “I think that’s a very important signal for the industry to hear they can find a highly educated life sciences workforce in a number of markets around the U.S.”

Georgia, with assets such as the Atlanta-based Centers for Disease Control and Prevention in its holster, indeed has gained recognition and attracted investments from top players in the industry, including Boston Scientific and Moderna.

CBRE’s top five life sciences markets — Boston, Washington, D.C., San Francisco, New York and San Diego — tote a high cost of living relative to salary earnings. Atlanta finds itself in a favorable situation as the annual cost of living averages $48,752, according to the U.S. Bureau of Labor Statistics. That low cost of living in comparison to other metros plays a vital role in not only talent retention, but real estate costs as well.

CBRE’s 2022 Life Sciences Talent Report ranked Atlanta 14th out of the top 25 life sciences research talent clusters. “Denver/Boulder, Minneapolis/St. Paul, Houston, Atlanta, Dallas/Ft. Worth and Miami, though sometimes overlooked, also have world-class health centers and universities, and in turn, sizable pools of life sciences research talent,” the report stated.

Institutions such as Emory University and Georgia Institute of Technology offer a wealth of skilled talent to add to over 75,000 life science employees in the state. Between 2016 and 2020 the state produced over 33,000 graduates with life sciences-related degrees. Over the next 10 years, Georgia occupations in the industry are expected to increase by 7{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, higher than the U.S. average.

Just Up the Street

Georgia Governor Brian Kemp announced in June 2022 that Boston Scientific plans to expand its Johns Creek facility. About 11 miles northwest of Initiative’s campus, what was once an EndoChoice site became part of Boston Scientific’s Endoscopy business in 2016 after a $210 million acquisition.

Construction underway at Intuitive’s Peachtree Corners site.

Photo by Adam Bruns

For over 40 years, the medical technology leader has designed and manufactured a portfolio of over 17,000 products. The company’s medical devices and therapies cater toward less-invasive procedures, its Georgia facility specializing in endoscopy.

Boston Scientific is investing $62.5 million to expand and integrate a new manufacturing and supply chain plant. The expansion will create 340 new jobs, adding to its roster of 300 employees in Fulton County.

“As we expand our presence in Georgia, we remain grateful to all of our local employees whose work is already making a difference for healthcare providers and patients around the world,” said Brad Sorenson, executive vice president of global operations at Boston Scientific, in a press release. “Our new site in Johns Creek will enable continued growth as we fulfill our mission to transform lives.”

Like the city of Peachtree Corners, Fulton County figures prominently in Atlanta’s budding life sciences market. According to Georgia Power’s 2021 Life Sciences Database there are 110 medical device companies in Georgia, employing over 10,000. The sector accounts for $2.8 billion of Georgia’s Gross Regional Product.

Georgia’s potential to be one of the next big medical devices markets is not a far-fetched idea.

Connecting unhealthy lifestyles to COVID-19 deaths

The American Journal of Medicine has published an write-up recognizing the connection involving harmful life style behaviors and the a single million COVID-19 deaths in the United States. Dr. Carl “Chip” Lavie, Clinical Director Cardiac Rehabilitation and Avoidance at the John Ochsner Coronary heart and Vascular Institute was a senior writer on this manuscript.

In 2022, the United States surpassed a person million COVID-19 linked deaths. The publication states there is a substantial affiliation amongst unhealthy behaviors and disorders this kind of as very low physical exercise, weight problems, diabetic issues and using tobacco, and poorer outcomes from COVID-19 infections.

“Clinicians have long been informed of the link involving improved mortality fees and unhealthy existence,” explained Dr. Lavie. “People who are living sedentary life with bad eating behavior and numerous serious conditions are usually much more prone to detrimental wellbeing outcomes.”

The report clarifies that the present-day condition of health and fitness results has been developing for a long time and really should be viewed as a syndemic, which is the simultaneous event of two commonplace health and fitness ailments or endemics. In this report, the authors evaluate geographic maps of the Unites States outlining COVID-19 deaths, various way of living behaviors, obesity, and continual ailments. With this, a sample is evident and pretty alarming for healthcare professionals.

“The actuality of this comparison should be very eye-opening for many,” explained Lavie. “The only way to overcome the syndemic we are enduring is to boost healthier life and handle the wellness needs of all, especially people in underserved communities who have been disproportionately impacted by lousy results related to persistent disorders and COVID-19.”

A lot more details:
Ross Arena et al, Mapping A person Million COVID-19 Fatalities and Harmful Way of life Behaviors in the United States: Recognizing the Syndemic Sample and Getting Action, The American Journal of Drugs (2022). DOI: 10.1016/j.amjmed.2022.06.006

Supplied by
Ochsner Health and fitness Program

Quotation:
Connecting unhealthy life to COVID-19 deaths (2022, November 10)
retrieved 11 November 2022
from https://medicalxpress.com/news/2022-11-harmful-lifestyles-covid-deaths.html

This document is subject to copyright. Apart from any fair dealing for the objective of non-public review or exploration, no
aspect may possibly be reproduced devoid of the created permission. The information is delivered for details functions only.